Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Daichi, Takizawa"'
Autor:
Takashi Iizumi, Toshiyuki Okumura, Naoyuki Hasegawa, Kazunori Ishige, Kuniaki Fukuda, Emiko Seo, Hirokazu Makishima, Hikaru Niitsu, Mizuki Takahashi, Yuta Sekino, Hiroaki Takahashi, Daichi Takizawa, Yoshiko Oshiro, Keiichiro Baba, Motohiro Murakami, Takashi Saito, Haruko Numajiri, Masashi Mizumoto, Kei Nakai, Hideyuki Sakurai
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Aim Hepatocellular carcinoma (HCC) with bile duct invasion (BDI) (BDIHCC) has a poor prognosis. Moreover, due to the paucity of reports, there is no consensus regarding optimal management of this clinical condition yet. The aim of this study
Externí odkaz:
https://doaj.org/article/73ce21dbb0ed4c698e80af013a769c02
Autor:
Takashi Iizumi, Hitoshi Ishikawa, Yuta Sekino, Keiichi Tanaka, Daichi Takizawa, Hirokazu Makishima, Haruko Numajiri, Masashi Mizumoto, Kei Nakai, Toshiyuki Okumura, Hideyuki Sakurai
Publikováno v:
Journal of Medical Radiation Sciences, Vol 69, Iss 2, Pp 198-207 (2022)
Abstract Introduction To confirm the feasibility of hypofractionated proton beam therapy (PBT), we compared the acute adverse event rates and International Prostate Symptom Score (IPSS) in prostate cancer patients treated with hypofractionated versus
Externí odkaz:
https://doaj.org/article/61c0c9f43dc14ec6b5f0276571d2677e
Autor:
Yoshiko Oshiro, Masashi Mizumoto, Yuta Sekino, Kazushi Maruo, Toshiki Ishida, Taisuke Sumiya, Masatoshi Nakamura, Ayako Ohkawa, Daichi Takizawa, Toshiyuki Okumura, Yoshio Tamaki, Hideyuki Sakurai
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 29, Iss , Pp 54-59 (2021)
Objectives: To estimate appropriate dose-volume parameters for avoidance of pneumonitis in use of chemoradiotherapy and durvalumab for treatment of lung cancer. Materials and methods: Patients with non-small cell lung cancer treated with concurrent c
Externí odkaz:
https://doaj.org/article/87701c5565ca43bdb4ea569c48145d37
Autor:
Satoshi Takakusagi, Naoto Saito, Takashi Ueno, Takeshi Hatanaka, Masashi Namikawa, Hiroki Tojima, Daichi Takizawa, Atsushi Naganuma, Takashi Kosone, Hirotaka Arai, Ken Sato, Satoru Kakizaki, Hitoshi Takagi, Toshio Uraoka
Publikováno v:
DEN Open, Vol 2, Iss 1, Pp n/a-n/a (2022)
Abstract Objectives The changes in portal hypertension after achieving a sustained viral response (SVR) by direct‐acting antivirals (DAAs) have not been fully elucidated. Consequently, noninvasive and inexpensive predictors need to be investigated.
Externí odkaz:
https://doaj.org/article/2dc4bdfc48e44abda2578cb3c9fdc6f3
Autor:
Masaaki Kondo, Manabu Morimoto, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Hiroshi Aikata, Takeshi Hatanaka, Daichi Takizawa, Kotaro Matsunaga, Chiaki Okuse, Michihiro Suzuki, Masataka Taguri, Takako Ishibashi, Kazushi Numata, Shin Maeda, Katsuaki Tanaka
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background The efficacy of hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma (HCC) remains unclear. We conducted a multi-center randomized phase II study comparing a sequential HAIC-sorafenib regimen versus
Externí odkaz:
https://doaj.org/article/d171f0802f7e4830bd1e315ef0ce26b0
Autor:
Soichiro Shimizu, Ken Sato, Kenta Ito, Aoi Kita, Kousuke Aihara, Yumeo Tateyama, Takahiro Abe, Mitsuhiko Shibasaki, Setsuo Yamazaki, Yasumori Fukai, Kenichi Iizuka, Daichi Takizawa, Hirotaka Arai, Munenori Ide, Toshio Uraoka
Publikováno v:
Kanzo. 63:530-537
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::514eff27d103b4cefe7595d6f243b91e
https://doi.org/10.2957/kanzo.63.530
https://doi.org/10.2957/kanzo.63.530
Autor:
Genya, Mitani, Kenji, Serigano, Tomonori, Takagaki, Kosuke, Hamahashi, Daichi, Takizawa, Yasuyuku, Sogo, Masato, Sato, Masahiko, Watanabe
Publikováno v:
The Journal of Knee Surgery.
Several combined procedures have been reported for treating recurrent patellofemoral instability (RPI) with various types and severity of morphological abnormalities, but none have identified absolute threshold values as indications for surgery. We p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79990f12254fa3cdfefed55c55be310e
https://doi.org/10.1055/a-2001-6565
https://doi.org/10.1055/a-2001-6565
Autor:
Masashi Mizumoto, Daichi Takizawa, Keiichi Tanaka, Toshiyuki Okumura, Hitoshi Ishikawa, Takashi Iizumi, Kei Nakai, Hideyuki Sakurai, Hirokazu Makishima, Haruko Numajiri, Yuta Sekino
Publikováno v:
Journal of Medical Radiation Sciences. 69:198-207
INTRODUCTION To confirm the feasibility of hypofractionated proton beam therapy (PBT), we compared the acute adverse event rates and International Prostate Symptom Score (IPSS) in prostate cancer patients treated with hypofractionated versus conventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a6e68297d0cafe934c6e77535da333c
https://doi.org/10.1002/jmrs.551
https://doi.org/10.1002/jmrs.551
Autor:
Yasushi Shimada, Takashi Hoshino, Tamon Nagashima, Toshio Uraoka, Takashi Ueno, Atsushi Naganuma, Hiroki Tojima, Masashi Namikawa, Hitoshi Takagi, Ken Sato, Daichi Takizawa, Takeshi Hatanaka, Hirotaka Arai, Satoshi Takakusagi, Satoru Kakizaki
Publikováno v:
Internal Medicine
Objective Chronic hepatitis C virus (HCV) infection carries a residual risk of hepatocarcinogenesis even after viral elimination, so appropriate follow-up is necessary. The present study investigated the current hospital visits and hepatocarcinogenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32845f6a1ba1e64f0b44dc6670070494
https://doi.org/10.2169/internalmedicine.6591-20
https://doi.org/10.2169/internalmedicine.6591-20
Autor:
Toshiyuki Okumura, Masashi Mizumoto, Yoshiko Oshiro, Daichi Takizawa, Toshiki Ishida, A. Ohkawa, Kazushi Maruo, Hideyuki Sakurai, Taisuke Sumiya, Masatoshi Nakamura, Yuta Sekino, Yoshio Tamaki
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 29, Iss, Pp 54-59 (2021)
Clinical and Translational Radiation Oncology, Vol 29, Iss, Pp 54-59 (2021)
Highlights • This is a study focus on radiation dose-volume parameters in use of durvalumab. • Dose-volume relation and pneumonitis was retrospectively investigated in 91 patients. • Pneumonitis developed in 88% patients at a median of 4.1 mont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11063bc3d37fd6a9325d3a550a1fa9cc
https://tsukuba.repo.nii.ac.jp/records/2002478
https://tsukuba.repo.nii.ac.jp/records/2002478